Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Krell

Showing results (91-100 of 135) with videos related to

Pageof 14
Sort By:
Genome Research|December 25, 2015
TP53 regulates miRNA association with AGO2 to remodel the miRNA-mRNA interaction networkJonathan Krell, Justin Stebbing, Claudia Carissimi, et al.
Oncotarget|March 22, 2018
Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatmentsCosti Alifrangis, Philip Carter, Biancastella Cereser, et al.
Molecular Diagnosis & Therapy|April 12, 2012
The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasisJonathan Krell, Adam E Frampton, Jimmy Jacob, et al.
Future Oncology (London, England)|June 1, 2014
The prognostic role of circulating tumor cells in heavily pretreated individuals with a low life expectancyJustin Stebbing, Victoria Harding, Catherine E Urch, et al.
Oncotarget|March 31, 2018
Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancyPhilip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Oncotarget|February 22, 2018
Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancyPhilip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Oncotarget|May 1, 2018
Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plansPhilip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Non-Coding RNA|August 25, 2022
Polymeric Carriers for Delivery of RNA Cancer TherapeuticsSofía Mirón-Barroso, Joana S Correia, Adam E Frampton, et al.
Oncotarget|March 7, 2018
Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?Philip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Oncotarget|March 31, 2018
Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?Philip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Pageof 14

Showing results (91-100 of 135) with videos related to

Sort By:
Pageof 14
Genome Research|December 25, 2015
TP53 regulates miRNA association with AGO2 to remodel the miRNA-mRNA interaction networkJonathan Krell, Justin Stebbing, Claudia Carissimi, et al.
Oncotarget|March 22, 2018
Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatmentsCosti Alifrangis, Philip Carter, Biancastella Cereser, et al.
Molecular Diagnosis & Therapy|April 12, 2012
The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasisJonathan Krell, Adam E Frampton, Jimmy Jacob, et al.
Future Oncology (London, England)|June 1, 2014
The prognostic role of circulating tumor cells in heavily pretreated individuals with a low life expectancyJustin Stebbing, Victoria Harding, Catherine E Urch, et al.
Oncotarget|March 31, 2018
Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancyPhilip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Oncotarget|February 22, 2018
Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancyPhilip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Oncotarget|May 1, 2018
Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plansPhilip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Non-Coding RNA|August 25, 2022
Polymeric Carriers for Delivery of RNA Cancer TherapeuticsSofía Mirón-Barroso, Joana S Correia, Adam E Frampton, et al.
Oncotarget|March 7, 2018
Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?Philip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Oncotarget|March 31, 2018
Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?Philip Carter, Costi Alifrangis, Biancastella Cereser, et al.
Pageof 14